SCHIMMEL PAUL bought ATYR

May 27, 2026 · Form 4 insider transaction

SCHIMMEL PAUL bought 100,000 shares of aTyr Pharma, Inc. at $0.50 per share, a transaction worth $49.6K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Acquired (buy-side)
Shares
100,000
Price
$0.50
Total value
$49.6K
RoleDirector
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMay 27, 2026
Filing dateMay 28, 2026
Shares owned after779,143
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

Represents weighted average price for the shares. The shares were purchased at prices ranging from $0.4907 to $0.50 per share. The Reporting Person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.; These shares are owned directly by Schimmel Revocable Trust U/A Dtd 9/6/2000. The Reporting Person and his spouse are trustees of the Schimmel Revocable Trust U/A Dtd 9/6/2000.

View the original Form 4 on SEC EDGAR